| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000225037.1 |
AKT inhibitor VIII |
Bladder urothelial carcinoma |
0.038897948 |
Resistant |
| ENSG00000225037.1 |
AKT inhibitor VIII |
Breast invasive carcinoma |
0.048394792 |
Sensitive |
| ENSG00000225037.1 |
AKT inhibitor VIII |
Liver hepatocellular carcinoma |
0.003831077 |
Sensitive |
| ENSG00000225037.1 |
AKT inhibitor VIII |
Sarcoma |
0.017228753 |
Sensitive |
